CRANE STRATEGIES

Registrant on federal lobbying filings · filed 2025 to 2026

$740,000 Income reported

2 Clients represented

12 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (400927689), not by name.

Clients 2

SIGA TECHNOLOGIES $440,000 6 filings
REGENERON PHARMACEUTICALS, INC. $300,000 6 filings

Lobbyists named 1

STEVEN CRANE 12 filings · through 2026 Subcommittee clerk, House Committee on Appropriations

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

Reported by year 2 years

2026 $260,000 4 filings
2025 $480,000 8 filings

Issues lobbied 1

Budget/Appropriations 12

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Health & Human Services, Dept of (HHS) 12
HOUSE OF REPRESENTATIVES 12
SENATE 12

Recent filings 12 total

Q2

REGENERON PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Aug 3, 2026

View → Q2

SIGA TECHNOLOGIES

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $80,000 income · posted Aug 3, 2026

View → Q1

REGENERON PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $50,000 income · posted May 4, 2026

View → Q1

SIGA TECHNOLOGIES

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $80,000 income · posted May 4, 2026

View → Q4

REGENERON PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $50,000 income · posted Jan 21, 2026

View → Q4

SIGA TECHNOLOGIES

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $80,000 income · posted Jan 21, 2026

View → Q3

REGENERON PHARMACEUTICALS, INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $50,000 income · posted Oct 1, 2025

View → Q3

SIGA TECHNOLOGIES

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $80,000 income · posted Oct 1, 2025

View → Q2

REGENERON PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $50,000 income · posted Jul 1, 2025

View → Q2

SIGA TECHNOLOGIES

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $70,000 income · posted Jul 1, 2025

View → Q1

REGENERON PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $50,000 income · posted May 5, 2025

View → Q1

SIGA TECHNOLOGIES

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $50,000 income · posted May 5, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.